Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial
- PMID: 32217951
- DOI: 10.1097/AOG.0000000000003780
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial
Comment in
-
In Reply.Obstet Gynecol. 2020 Apr;135(4):970-971. doi: 10.1097/AOG.0000000000003782. Obstet Gynecol. 2020. PMID: 32217954 No abstract available.
Comment on
-
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol. 2020 Jan;135(1):158-165. doi: 10.1097/AOG.0000000000003620. Obstet Gynecol. 2020. PMID: 31809439 Clinical Trial.
References
-
- Creinin MD, Hou MY, Dalton L, Steward R, Chen MJ. Mifepristone antagonization with progesterone to prevent medical abortion: a randomized controlled trial. Obstet Gynecol 2020;135:158–65.
-
- Delgado G, Condly S, Davenport M, Tinnakornsrisuphap T, Mack J, Khauv V, et al. A case series detailing the successful reversal of the effects of mifepristone using progesterone. Issues Law Med 2018;33:21–31.
-
- Davenport M, Delgado G, Khauv V. Embryo survival after mifepristone: review of the literature. Issues Law Med 2017;32:3–18.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical